| EMT | Epithelial-Mesenchymal Transition |
| MET | Mesenchymal-Epithelial Transition |
| BPH | Benign Prostatic Hyperplasia |
| CAF | Cancer-Associated Fibroblasts |
| HIF-1 | Hypoxia-Induced Factor-1 |
| TROAP | Trophinin-Associated Protein |
| IDC | Invasive Ductal Carcinoma |
| NRP1 | Neuropilin-1 |
| miR200 | MicroRNA200 |
| PSA | Prostate Specific Antigen |
| DRE | Digital Rectal Examination |
| HSP | Heat Shock Protein |
| AR | Androgen Receptor |
| CTHRC1 | Collagen Triple Helix Repeat-Containing 1 |
| LNMAS | Lymph node metastasis-associated suppressor |
| KLK4 | Kallikrein-related peptidase 4 |
| CTC | Circulating Tumor Cells |
| PES | Phenylethynesulfonamide |
| FDA | US Food and Drug Administration |
| mCRPC | Metastatic Castration-Resistant Prostate Cancer |
| ADT | Androgen Deprivation Therapy |
| SNAG | Snail/Gfi-1 |